Obesity

Scary Charts (Beyond BMI) – 06.04.23

/ SupremeCmdr / 3 Comments

The value of the BMI for tracking the current epidemic of obesity is clearly illustrated in the study by Rodgers et al., which traced the change in the BMI for many subgroups of the US population from 1962 to the year 2000 [23]. (See Figure 1) They showed that the US epidemic of obesity began about 1975 in all age, sex and ethnic groups and continued over the next 25 years. This fact limits the plausible explanations for the current epidemic of obesity. Rodgers and colleagues believe that it is implausible that each age, sex and ethnic group, with massive differences in life experience and attitudes, had a simultaneous decline in willpower related to healthy nutrition or exercise, or that intrauterine exposures played a major causative role. Likewise, changes in genetic make-up are unlikely to have occurred over this short period and to have affected all age groups simultaneously. Similarly, they note that it is unlikely that any factor with a long induction period had a major role in the US epidemic. Rather, they believe that the epidemic must have been caused by factors that led to rapid population-wide changes such as changes in the food supply, and I tend to agree with their conclusion.

Beyond BMI by George A. Bray – Nutrients 2023, 15(10), 2254 – https://doi.org/10.3390/nu15102254

Agree.

Tirzepatide (another GLP-1 receptor agonist post)

/ SupremeCmdr / Leave a comment

Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes — https://doi.org/10.2337/dc22-1710

To reduce the number of clicks the rest of this post is a repost of April Fools 2023 (this is a GLP-1 receptor agonist post). Enjoy!

Ozempic and a similar drug, Wegovy, are weekly shots you give yourself that cause the body to produce insulin. Insulin lowers blood sugar, slows digestion and makes people feel full. Carter-Williams tried it and was amazed.

“You are not hungry,” she says. “Like, I actually have to set timers to make sure that I do eat, because otherwise you actually forget to eat.”

‘You forget to eat’: How Ozempic went from diabetes medicine to blockbuster diet drug https://www.npr.org/2023/04/01/1166781510/ozempic-weight-loss-drug-big-business

Everyone wants the easy way out. I sometimes forget to eat but not because of a miracle drug. You wonder if those of us wanting to lose weight know you can’t stop taking this drug once you start it.

Patients discontinuing the use of weight-loss drugs such as Wegovy risk regaining their original body weight in about five years, a Novo Nordisk official said on Wednesday.

Novo Nordisk Says Stopping Obesity Drug May Cause Full Weight Regain in 5 Years–https://www.medscape.com/viewarticle/990267?src=rss

Side effects?

Just a few https://www.wegovy.com/taking-wegovy/side-effects.html

  • Possible thyroid tumors, including cancer.
  • Inflammation of your pancreas (pancreatitis)
  • Gallbladder problems
  • Increased risk of low blood sugar (hypoglycemia) in patients with type 2 diabetes, especially those who also take medicines for type 2 diabetes such as sulfonylureas or insulin
  • Kidney problems (kidney failure)
  • Serious allergic reactions
  • Change in vision in people with type 2 diabetes.
  • Increased heart rate
  • Depression or thoughts of suicide.

So if you want to lose weight by taking a GLP-1 receptor agonist remember the risks of side effects including the real possibility of having to take a drug that costs up to $1600.00 a month for the rest of your life.

Good luck with that. This joke’s on you.

April Fools 2023 (this is a GLP-1 receptor agonist post)

/ SupremeCmdr / 6 Comments

Ozempic and a similar drug, Wegovy, are weekly shots you give yourself that cause the body to produce insulin. Insulin lowers blood sugar, slows digestion and makes people feel full. Carter-Williams tried it and was amazed.

“You are not hungry,” she says. “Like, I actually have to set timers to make sure that I do eat, because otherwise you actually forget to eat.”

‘You forget to eat’: How Ozempic went from diabetes medicine to blockbuster diet drug https://www.npr.org/2023/04/01/1166781510/ozempic-weight-loss-drug-big-business

Everyone wants the easy way out. I sometimes forget to eat but not because of a miracle drug. You wonder if those of us wanting to lose weight know you can’t stop taking this drug once you start it.

Patients discontinuing the use of weight-loss drugs such as Wegovy risk regaining their original body weight in about five years, a Novo Nordisk official said on Wednesday.

Novo Nordisk Says Stopping Obesity Drug May Cause Full Weight Regain in 5 Years–https://www.medscape.com/viewarticle/990267?src=rss

Side effects?

Just a few https://www.wegovy.com/taking-wegovy/side-effects.html

  • Possible thyroid tumors, including cancer.
  • Inflammation of your pancreas (pancreatitis)
  • Gallbladder problems
  • Increased risk of low blood sugar (hypoglycemia) in patients with type 2 diabetes, especially those who also take medicines for type 2 diabetes such as sulfonylureas or insulin
  • Kidney problems (kidney failure)
  • Serious allergic reactions
  • Change in vision in people with type 2 diabetes.
  • Increased heart rate
  • Depression or thoughts of suicide.

So if you want to lose weight by taking a GLP-1 receptor agonist remember the risks of side effects including the real possibility of having to take a drug that costs up to $1600.00 a month for the rest of your life.

Good luck with that. This joke’s on you.

The Economic Cost of Obesity

/ SupremeCmdr / Leave a comment

CONCLUSIONS: The 2-part models of instrumental variables, which estimate the causal effects of obesity on direct medical costs, showed that the effect of obesity is greater than suggested by previous studies, which estimated only correlations. Much of the aggregate national cost of obesity—$260.6 billion—represents external costs, providing a rationale for interventions to prevent and reduce obesity.

J Manag Care Spec Pharm, 2021 Mar;27(3):354-366.
https://doi.org/10.18553/jmcp.2021.20410

HT to https://www.healthcare-economist.com/2023/02/08/estimating-the-economic-cost-of-obesity/

Diabesity

/ SupremeCmdr / Leave a comment

Strong, consistent evidence shows that managing obesity can delay progression of prediabetes to type 2 diabetes. Obesity management is also highly beneficial in treating type 2 diabetes, based on the degree of weight loss achieved. Losing excess weight improves glycemic control, reduces the need for glucose-lowering medications, can substantially reduce A1C, and can even promote sustained diabetes remission.

Diabesity Clin Diabetes 2022;40(4):392–393 — https://doi.org/10.2337/cd22-0088

Remember, Stay as Thin as You Can as Long as You Can

The State of Obesity 2021

/ SupremeCmdr / 6 Comments
Oklahoma tied for 9th

Nationally, 16 states now have adult obesity rates at or above 35 percent.  Reaching the 35 percent or higher level this year were Delaware, Iowa, Ohio, and Texas. The twelve states that continue to have adult rates above 35 percent are: Alabama, Arkansas, Indiana, Kansas, Kentucky, Louisiana, Michigan, Mississippi, Oklahoma, South Carolina, Tennessee, and West Virginia.  (See rates chart for data on all 50 states and the District of Columbia).

State of Obesity 2021: Better Policies for a Healthier America — https://www.tfah.org/report-details/state-of-obesity-2021/

In 2012, no state had an adult obesity rate above 35 percent.

In 2000, no state had an adult obesity rate above 25 percent.

The full report can be downloaded from the link above. My post on the 2020 report is here: The State of Obesity 2020

As a former 370 pound human my experience and knowledge can help those struggling with their weight.

Meanwhile work continues on my Future Best Seller.